Clinical trial
VITAL - Individualising Therapy for Neovascular AMD With Aflibercept
NCT02441816 is registered in ClinicalTrials.gov with Moorfields Eye Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VITAL - Individualising Therapy for Neovascular AMD With Aflibercept
- Lead sponsor
- Moorfields Eye Hospital NHS Foundation Trust
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- January 26, 2018
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age related macular degeneration